ES2524382R1 - Uso de polihidroxiaciltioalcanoatos como bactericidas - Google Patents

Uso de polihidroxiaciltioalcanoatos como bactericidas Download PDF

Info

Publication number
ES2524382R1
ES2524382R1 ES201330821A ES201330821A ES2524382R1 ES 2524382 R1 ES2524382 R1 ES 2524382R1 ES 201330821 A ES201330821 A ES 201330821A ES 201330821 A ES201330821 A ES 201330821A ES 2524382 R1 ES2524382 R1 ES 2524382R1
Authority
ES
Spain
Prior art keywords
bactericides
polyhydroxiaciltioalcanoates
polyhydroxyacylthioalkanoates
elements
relates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES201330821A
Other languages
English (en)
Other versions
ES2524382B1 (es
ES2524382A2 (es
Inventor
Nina DINJASKI
José Luis GARCÍA LÓPEZ
Mª Auxiliadora PRIETO JIMÉNEZ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Consejo Superior de Investigaciones Cientificas CSIC
Original Assignee
Consejo Superior de Investigaciones Cientificas CSIC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Consejo Superior de Investigaciones Cientificas CSIC filed Critical Consejo Superior de Investigaciones Cientificas CSIC
Priority to ES201330821A priority Critical patent/ES2524382B1/es
Publication of ES2524382A2 publication Critical patent/ES2524382A2/es
Publication of ES2524382R1 publication Critical patent/ES2524382R1/es
Application granted granted Critical
Publication of ES2524382B1 publication Critical patent/ES2524382B1/es
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L67/00—Compositions of polyesters obtained by reactions forming a carboxylic ester link in the main chain; Compositions of derivatives of such polymers
    • C08L67/04—Polyesters derived from hydroxycarboxylic acids, e.g. lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/795—Polymers containing sulfur
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P11/00—Preparation of sulfur-containing organic compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Polymers & Plastics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Detergent Compositions (AREA)
  • Paints Or Removers (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Uso de Polihidroxiaciltioalcanoatos como bactericidas.#La presente invención se refiere al uso de polihidroxiaciltioalcanoatos, hidrolizados de estos, productos aislados del hidrolizado o composiciones que comprenden estos elementos como bactericidas. Además la presente invención se refiere al uso de estos elementos para la elaboración de medicamentos, preferiblemente bactericidas, la fabricación materiales bactericidas o recubrimiento de materiales.
ES201330821A 2013-06-04 2013-06-04 Uso de polihidroxiaciltioalcanoatos como bactericidas Expired - Fee Related ES2524382B1 (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES201330821A ES2524382B1 (es) 2013-06-04 2013-06-04 Uso de polihidroxiaciltioalcanoatos como bactericidas

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES201330821A ES2524382B1 (es) 2013-06-04 2013-06-04 Uso de polihidroxiaciltioalcanoatos como bactericidas

Publications (3)

Publication Number Publication Date
ES2524382A2 ES2524382A2 (es) 2014-12-05
ES2524382R1 true ES2524382R1 (es) 2014-12-18
ES2524382B1 ES2524382B1 (es) 2015-10-05

Family

ID=51999954

Family Applications (1)

Application Number Title Priority Date Filing Date
ES201330821A Expired - Fee Related ES2524382B1 (es) 2013-06-04 2013-06-04 Uso de polihidroxiaciltioalcanoatos como bactericidas

Country Status (1)

Country Link
ES (1) ES2524382B1 (es)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2399765A2 (es) * 2010-09-21 2013-04-03 Consejo Superior De Investigaciones Cientificas (Csic) Sintesis de polihidroxialcanoatos (pha) con grupos tioesteres en la cadena lateral

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2399765A2 (es) * 2010-09-21 2013-04-03 Consejo Superior De Investigaciones Cientificas (Csic) Sintesis de polihidroxialcanoatos (pha) con grupos tioesteres en la cadena lateral

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
ESCAPA, I. F. et al. ¿Disruption of ?-oxidation pathway in Pseudomonas putida KT2442 to produce new functionalized PHAs with thioester groups¿. Applied Microbiology and Biotechnology, 2011, Vol. 89, páginas 1583-1598. Ver página 1589, columna 2, párrafo 2 ¿ página 1591, columna 2, párrafo 2; figura 6a. *
MAUCLAIRE, L: et al. ¿Factors controlling bacterial attachment and biofilm formation on medium-chain-length polyhydroxyalkanoates (mcl-PHAs)¿. Colloids and Srufaces B: Biointerfaces, 2010, Vol. 76, páginas 104-111. Ver Resumen; página 104, columna 1. *
RUTH, K. et al. ¿Efficient production of (R)-3-hydroxycarboxylic acids by biotechnological conversion of polyhydroxyalkanoates and their purification¿. Biomacromolecules, 2007, Vol 8, Nº 1, páginas 279-86. Ver Resumen; ¿Materiales y Métodos¿; ¿Resultados y Discusión¿, Tabla 1. *
SANDOVAL, A. et al. ¿Production of 3-hydroxy-n-phenylalkanoic acids by a genetically engineered strain of Pseudomonas putida¿. Applied Microbiology and Biotechnology, 2005, Vol. 67, páginas 97-105. Ver Resumen; Introducción. *

Also Published As

Publication number Publication date
ES2524382B1 (es) 2015-10-05
ES2524382A2 (es) 2014-12-05

Similar Documents

Publication Publication Date Title
ECSP21072161A (es) Composiciones de liberación retardada de linaclotida
BR112017010173A2 (pt) composição para tratamento de tecido
MX2016016666A (es) Derivados de acido boronico y usos terapeuticos de los mismos.
MX2016015093A (es) Derivados de acido boronico y sus usos terapeuticos.
BR112017009497A2 (pt) polinucleotídeos de aadc para o tratamento da doença de parkinson
UA116648C2 (uk) Фумарати як проліки та їх застосування при лікуванні різних захворювань
EA201692526A1 (ru) Замещенные [1,2,4]триазольные соединения
UY35661A (es) Nuevos derivados fosfatos, su procedimiento de preparación y las composiciones farmacéuticas que lo s contienen
MX2017014035A (es) Formas solidas novedosas.
BR112017010177A2 (pt) composição para tratamento de tecido
CO2018005753A2 (es) Composición hemostática
CO2018002438A2 (es) Composiciones de micropartículas que comprenden saflufenacil
CL2018001210A1 (es) Compuestos de criptoficina novedosos y productos conjugados, su preparación y su uso terapéutico.
MX345926B (es) Nuevas composiciones, producción de las mismas y uso de las mismas para la producción de poliamidas coladas.
CL2014003052A1 (es) Anticuerpos para la neutralización de la influenza
CL2016000038A1 (es) Piraxolo-piridinaminas sustituidas
BR112015023878A2 (pt) composto, composição farmacêutica, e, uso de um composto
BR112017022439A2 (pt) composições para higiene bucal.
CO2017004504A2 (es) Composición que comprende al menos un polvo seco obtenido por secado por atomización para aumentar la estabilidad de la formulación
BR112014020008A8 (pt) composição farmacêutica, uso da mesma, e, processo para a fabricação de uma formulação.
BR112017007753A2 (pt) uso de uma composição cosmética que compreende ácido 10-hidroxiesteárico.
CY1118913T1 (el) Νεοι ανθελονοσιακοι παραγοντες
CU20180044A7 (es) Derivados novedosos de diamino piridina
BR112017006338A2 (pt) processos para preparação de 2,5-diclorofenol
ES2524382B1 (es) Uso de polihidroxiaciltioalcanoatos como bactericidas

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 2524382

Country of ref document: ES

Kind code of ref document: B1

Effective date: 20151005

FD2A Announcement of lapse in spain

Effective date: 20210915